Researchers aim to facilitate evidence-based decisions.
WASHINGTON -- A new framework developed by researchers at the National Pharmaceutical Council (NPC) and AcademyHealth is being touted as a way to bridge the gap between the "supply" of evidence developed by researchers and the "demand" for evidence by payers.
The gap stems from payers typically favoring evidence from randomized controlled trials over other study designs, including real-world or observational studies that are based upon electronic health records, patient registries or administrative claims, NPC remarked.
"This gap between supply and demand is complicated by the tendency of decision makers to assess evidence based on study design rather than whether the evidence credibly answers the question that's being asked," commented Jennifer Graff, vice president for comparative effectiveness research at NPC.
An article introducing the framework appears in the September issue of The American Journal of Managed Care.
|Printer friendly Cite/link Email Feedback|
|Publication:||Chain Drug Review|
|Article Type:||Brief article|
|Date:||Oct 26, 2015|
|Previous Article:||Gaps in measurement hamper bid to improve quality.|
|Next Article:||When it comes to Rx, convenience a big factor.|